Cargando…

Parkinson’s disease, L-DOPA, and endogenous morphine: A revisit

Clinical observations stemming from widespread employment of restorative L-3,4-dihydroxyphenylalanine (L-DOPA) therapy for management of dyskinesia in Parkinson’s Disease (PD) patients implicate a regulatory role for endogenous morphine in central nervous system dopamine neurotransmission. Reciproca...

Descripción completa

Detalles Bibliográficos
Autores principales:	Stefano, George B., Mantione, Kirk J., Králíčková, Milena, Ptacek, Radek, Kuzelova, Hana, Esch, Tobias, Kream, Richard M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	International Scientific Literature, Inc. 2012
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3560700/ https://www.ncbi.nlm.nih.gov/pubmed/22847214 http://dx.doi.org/10.12659/MSM.883259

Ejemplares similares

Low dose morphine adjuvant therapy for enhanced efficacy of antipsychotic drug action: Potential involvement of endogenous morphine in the pathophysiology of schizophrenia
por: Stefano, George B., et al.
Publicado: (2012)

Convergent dysregulation of frontal cortical cognitive and reward systems in eating disorders
por: Stefano, George B., et al.
Publicado: (2013)

Comparing Bioinformatic Gene Expression Profiling Methods: Microarray and RNA-Seq
por: Mantione, Kirk J, et al.
Publicado: (2014)

The effects of morphine on Parkinson’s-related genes PINK1 and PARK2
por: Snyder, Christopher, et al.
Publicado: (2014)

Interactive effects of endogenous morphine, nitric oxide, and ethanol on mitochondrial processes
por: Kream, Richard M., et al.
Publicado: (2010)

Disruptive patterns of eating behaviors and associated lifestyles in males with ADHD
por: Ptacek, Radek, et al.
Publicado: (2014)

Dopamine D4 receptor gene DRD4 and its association with psychiatric disorders
por: Ptáček, Radek, et al.
Publicado: (2011)

Chronic alcohol exposure increases ganglia endogenous morphine levels
por: Zhu, Wei, et al.
Publicado: (2010)

Dysregulation of Nitric Oxide Signaling in Microglia: Multiple Points of Functional Convergence in the Complex Pathophysiology of Alzheimer Disease
por: Stefano, George B., et al.
Publicado: (2020)

Emerging Roles of Blood-Borne Intact and Respiring Mitochondria as Bidirectional Mediators of Pro- and Anti-Inflammatory Processes
por: Esch, Tobias, et al.
Publicado: (2020)

L-DOPA Is an Endogenous Ligand for OA1
por: Lopez, Vanessa M, et al.
Publicado: (2008)

Catechol-O-methyltransferase: potential relationship to idiopathic hypertension
por: Mantione, Kirk J., et al.
Publicado: (2010)

Selective Neuronal Mitochondrial Targeting in SARS-CoV-2 Infection Affects Cognitive Processes to Induce ‘Brain Fog’ and Results in Behavioral Changes that Favor Viral Survival
por: Stefano, George B., et al.
Publicado: (2021)

Revisiting the L-Dopa Response as a Predictor of Motor Outcomes After Deep Brain Stimulation in Parkinson’s Disease
por: Lin, Zhengyu, et al.
Publicado: (2021)

Targeting mitochondrial biogenesis for promoting health
por: Stefano, George B., et al.
Publicado: (2012)

Dysfunctional mitochondrial processes contribute to energy perturbations in the brain and neuropsychiatric symptoms
por: Büttiker, Pascal, et al.
Publicado: (2023)

Independent and sensory human mitochondrial functions reflecting symbiotic evolution
por: Stefano, George B., et al.
Publicado: (2023)

L-DOPA-therapy in Parkinson’s disease: some personal reflections on L-DOPA therapy from Vienna and Berlin
por: Riederer, Peter, et al.
Publicado: (2023)

Molecular Effects of L-dopa Therapy in Parkinson’s Disease
por: Dorszewska, Jolanta, et al.
Publicado: (2014)

Beyond L-DOPA: hope for Parkinson’s treatment and diagnosis
Publicado: (2017)

Reciprocal Evolution of Opiate Science from Medical and Cultural Perspectives
por: Stefano, George B., et al.
Publicado: (2017)

Microbiome: A Potential Component in the Origin of Mental Disorders
por: Stefano, George B., et al.
Publicado: (2017)

L-DOPA
por: Hornykiewicz, Oleh
Publicado: (2017)

The role of GRK6 in animal models of Parkinson's Disease and L-DOPA treatment
por: Managò, Francesca, et al.
Publicado: (2012)

L-DOPA in Parkinson’s Disease: Looking at the “False” Neurotransmitters and Their Meaning
por: Chagraoui, Abdeslam, et al.
Publicado: (2019)

Biomedical Perspectives of Acute and Chronic Neurological and Neuropsychiatric Sequelae of COVID-19
por: Stefano, George B., et al.
Publicado: (2022)

Vascular Dysfunction Associated with Type 2 Diabetes and Alzheimer’s Disease: A Potential Etiological Linkage
por: Wang, Fuzhou, et al.
Publicado: (2014)

Altered cerebellar connectivity in Parkinson's patients ON and OFF L-DOPA medication
por: Festini, Sara B., et al.
Publicado: (2015)

The Design and Evaluation of an l-Dopa–Lazabemide Prodrug for the Treatment of Parkinson’s Disease
por: Hoon, Monique, et al.
Publicado: (2017)

Inhaling xenon ameliorates l‐dopa‐induced dyskinesia in experimental parkinsonism
por: Baufreton, Jérôme, et al.
Publicado: (2018)

Receptor Ligands as Helping Hands to L-DOPA in the Treatment of Parkinson’s Disease
por: Bello, Fabio Del, et al.
Publicado: (2019)

An Integrative Approach to Treat Parkinson's Disease: Ukgansan Complements L-Dopa by Ameliorating Dopaminergic Neuronal Damage and L-Dopa-Induced Dyskinesia in Mice
por: Huh, Eugene, et al.
Publicado: (2019)

L-Dopa and Behavior
por: Kebabian, John
Publicado: (1974)

SARS-CoV-2, Trait Anxiety, and the Microbiome
por: Büttiker, Pascal, et al.
Publicado: (2021)

Readiness Potential in Parkinson's Disease: Effects of L-Dopa Therapy and Brain Transplants
por: Martínez, D. N. Velázquez, et al.
Publicado: (1992)

L-DOPA-Induced Dyskinesia in a Genetic Drosophila Model of Parkinson’s Disease
por: Blosser, Joshua A., et al.
Publicado: (2020)

Individual Magnetoencephalography Response Profiles to Short-Duration L-Dopa in Parkinson’s Disease
por: Peña, Edgar, et al.
Publicado: (2021)

Augmentation of Whole-Body Metabolic Status by Mind-Body Training: Synchronous Integration of Tissue- and Organ-Specific Mitochondrial Function
por: Stefano, George B., et al.
Publicado: (2019)

Chromosomal Processes in Mind-Body Medicine: Chronic Stress, Cell Aging, and Telomere Length
por: Esch, Tobias, et al.
Publicado: (2018)

Potential Immunoregulatory and Antiviral/SARS-CoV-2 Activities of Nitric Oxide
por: Stefano, George B., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_9844fc7o8rki1i9v57u6gs4cf6